(14231609), H. K., (9203073), I. G., (21633524), F. S. C., (3353012), S. V., (21259523), H. F. A., (4246147), M. M., . . . (14153205), A. A. M. (2024). Targeting HER2-positive breast cancer cells by a combination of dasatinib and BMS-202: Insight into the molecular pathways.
Chicago Style (17th ed.) Citation(14231609), Hadeel Kheraldine, Ishita Gupta (9203073), Farhan Sachal Cyprian (21633524), Semir Vranic (3353012), Halema F. Al-Farsi (21259523), Maysaloun Merhi (4246147), Said Dermime (79420), and Ala-Eddin Al Moustafa (14153205). Targeting HER2-positive Breast Cancer Cells by a Combination of Dasatinib and BMS-202: Insight into the Molecular Pathways. 2024.
MLA (9th ed.) Citation(14231609), Hadeel Kheraldine, et al. Targeting HER2-positive Breast Cancer Cells by a Combination of Dasatinib and BMS-202: Insight into the Molecular Pathways. 2024.